Retinal tears after posterior vitreous detachment and vitreous hemorrhage in patients on systemic anticoagulants

Eye

Volumn 25, Issue 8, 2011, Pages 1016-1019

  El Sanhouri, A A ^a   Foster, R E ^a   Petersen, M R ^a   Hutchins, R K ^a   Miller, D M ^a   Evans, T M ^a   Trichopoulos, N ^a   Riemann, C D ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

posterior vitreous detachment; retinal tears; vitreous hemorrhage

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREVALENCE; RETINA DETACHMENT; RETINA TEAR; RETINOPEXY; SYSTEMIC THERAPY; VITREOUS BODY DETACHMENT; VITREOUS HEMORRHAGE;

EID: 80051761846     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2011.106     Document Type: Article

References (20)

1. Mirshahi A, Hoehn F, Lorenz K, Hattenbach LO. Incidence of posterior vitreous detachment after cataract surgery. J Cataract Refract Surg 2009; 35: 987-991
2. Boldrey EE. Risk of retinal tears in patients with vitreous floaters. Am J Ophthalmol 1983; 96: 783-787 (Pubitemid 14204230)
3. Brod RD, Lightman DA, Packer AJ, Saras HP. Correlation between vitreous pigment granules and retinal breaks in eyes with acute posterior vitreous detachment. Ophthalmology 1991; 98: 1366-1369
4. Tasman WS. Posterior vitreous detachment and peripheral retinal breaks. Trans Am Acad Ophthalmol Otolaryngol 1968; 72: 217-224
5. Dayan MR, Jayamanne DG, Andrews RM, Griffiths PG. Flashes and floaters as predictors of vitreoretinal pathology: is follow-up necessary for posterior vitreous detachment? Eye 1996; 10: 456-458 (Pubitemid 26285554)
6. Byer NE. Natural history of posterior vitreous detachment with early management as the premier line of defense against retinal detachment. Ophthalmology 1994; 101: 1503-1514 (Pubitemid 24347048)
7. Sarrafizadeh R, Hassan TS, Ruby AJ. Incidence of retinal detachment and visual outcome in eyes presenting with posterior vitreous separation and dense fundusobscuring vitreous hemorrhage. Ophthalmology 2001; 108: 2273-2278 (Pubitemid 33096942)
8. Goodman SG, Huang W, Yan AT, Budaj A, Kennelly BM, Gore JM et al. The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. Am Heart J 2009; 158: 193-201
9. Mauskopf JA, Boye KS, Schmitt C, McCollam P, Birt J, Juniper MD et al. Adherence to guidelines for sensitivity analysis: cost-effectiveness analyses of dual oral antiplatelet therapy. J Med Econ 2009; 12: 141-153
10. Ross JS, Halm EA, Bravata DM. Use of stroke secondary prevention services: are there disparities in care? Stroke 2009; 40: 1811-1819
11. Firestone B, Mold JW. Type 2 diabetes: which interventions best reduce absolute risks of adverse events? J Fam Pract 2009; 58: E1
12. Satiani B. A Medicare primer. J Vasc Surg 2009; 50: 453-460
13. Di Minno MN, Prisco D, Ruocco AL, Mastronardi P, Massa S, Di Minno G. Perioperative handling of patients on antiplatelet therapy with need for surgery. Intern Emerg Med 2009; 4: 279-288
14. White RL, Cohen SP. Return-to-duty rates among coalition forces treated in a forward-deployed pain treatment center: a prospective observational study. Anesthesiology 2007; 107: 872-874
15. Charles S, Rosenfeld PJ, Gayer S. Medical consequences of stopping anticoagulant therapy before intraocular surgery or intravitreal injections. Retina 2007; 27(7): 813-815 (Pubitemid 47479373)
16. Benzimra JD, Johnston RL, Jaycock P, Galloway PH, Lambert G, Chung AK et al. The Cataract National Dataset electronic multicentre audit of 55,567 operations: antiplatelet and anticoagulant medications. Eye 2009; 23: 10-16
17. Beyan E, Beyan C, Vaizoglu SA. Predisposing preventable factors in patients with bleeding due to warfarin usage: evaluation of 114 patients. Clin Appl Thromb Hemost 2009; 16(6): 684-687
18. Yoo SH, Nah HW, JoMW, Kang DW, Kim JS, Koh JYet al. Age and body weight adjusted warfarin initiation program for ischaemic stroke patients. Eur J Neurol 2009; 16(10): 1100-1105
19. Lind M, Boman K, Johansson L, Nilsson TK, Ohlin AK, Birgander LS et al. Thrombomodulin as a marker for bleeding complications during warfarin treatment. Arch Intern Med 2009; 169: 1210-1215
20. Segal JB, McNamara RL, Miller MR, Kim N, Goodman SN, Powe NR et al. Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs. J Gen Intern Med 2000; 15: 56-67 (Pubitemid 30060940)